Navidea Biopharmaceuticals (NAVB) Files $100M Mixed Shelf; 3.17M Common for Shareholders
Navidea Biopharmaceuticals (AMEX: NAVB) filed a registration with the U.S. SEC to sell ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
